Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$AUPH Q1 '25 Earnings Results & Recap Aurinia Pharmaceuticals reported Q1 2025 EPS of $0.16, exceeding the estimate of $0.10, and revenue of $62.5M, exceeding the estimate of $61.11M; however, the company's full-year revenue guidance of $250M-$260M remains relatively narrow despite already exceeding the Q1 expectations.

Since Post

Full Details

Advertisement|Remove ads.